*********************************
There is now a CONTENT FREEZE for Mercury while we switch to a new platform. It began on Friday, March 10 at 6pm and will end on Wednesday, March 15 at noon. No new content can be created during this time, but all material in the system as of the beginning of the freeze will be migrated to the new platform, including users and groups. Functionally the new site is identical to the old one. webteam@gatech.edu
*********************************
"Translational MEMS-Based Technologies for Overcoming Sensory Loss in the Human Auditory and Vestibular Systems"
Pamela Bhatti, PhD
Assistant Professor
Microelectronics/Microsystems, Digital Signal Processing & Bioengineering
School of Electrical & Computer Engineering
Georgia Tech
Pamela Bhatti received a BS in Engineering Science (Bioengineering) from the University of California, Berkeley in 1989, an M.S. in Electrical Engineering from the University of Washington in 1993, and a PhD in Electrical Engineering from the University of Michigan, Ann Arbor in 2006 with an emphasis on Micro-electro Mechanical Systems (MEMS). Before completing her PhD, she researched the detection of breast cancer with ultrasound imaging at the University of Michigan's Department of Radiology (1997-1999). Her industry experience includes embedded systems software development at Microware Corporation, Des Moines, IA (1996-1997), local operating network applications development and customer support at Motorola Semiconductor in Austin, TX (1994-1995), and research and fabrication of controlled-release drug delivery systems at Alza Corporation in Palo Alto, CA (1986-1990). Pamela received the NSF CAREER Award in 2011. Committed to translating technology to the clinical setting, she is a KL2 Scholar with the Atlanta Clinical and Translations Sciences Institute, and an Adjunct Assistant Professor of Rehabilitative Medicine with the Emory School of Medicine. Bhatti’s research interests are in the area of biomedical sensors and subsystems including bioMEMS, neural prostheses: cochlear, modiolar, intraneural and vestibular and integration of controlled-release drug delivery technology with flexible neural recording/stimulating arrays.